Alexion Pharmaceuticals Inc. (ALXN) News Headlines

▮ More

Date

Headline

12/6/2019 9:03:37 AM Alexion Rejects Elliott Recommendation - Quick Facts

12/6/2019 8:34:10 AM Alexion Says Has Not Received Any Indications Of Interest Nor Have Rejected Any Proposals

11/22/2019 8:55:29 AM Alexion : Japan Okays Soliris For Prevention Of Relapse In Patients With NMOSD

11/22/2019 8:35:52 AM Alexion : Japan Approves SOLIRIS For Prevention Of Relapse In Patients With Neuromyelitis Optica Spectrum Disorder

10/23/2019 7:02:53 AM Alexion Pharmaceuticals Q3 19 Earnings Conference Call At 8:00 AM ET

10/23/2019 6:53:32 AM Alexion Pharma Raises 2019 Outlook

10/23/2019 6:43:31 AM Alexion Pharmaceuticals Inc. Q3 adjusted earnings Beat Estimates

10/23/2019 6:32:10 AM Alexion Q3 GAAP EPS $2.08, Up 41% From Prior Year

10/16/2019 6:47:40 AM Alexion Pharma To Acquire Achillion Pharma For About $930 Mln Cash

10/16/2019 6:33:14 AM Alexion To Acquire Achillion For Initial All-cash Transaction For $6.30/Shr

10/11/2019 5:54:17 AM MITO Empowered, FPRX Cuts Another 70 Jobs, Second Death In Legionnaires Outbreak

10/10/2019 4:14:06 PM Alexion Pharma Appoints As Tanisha Carino As EVP And Chief Corporate Affairs Officer

10/10/2019 7:35:28 AM Alexion,Stealth Announce Deal For Option To Co-Develop And Commercialize Elamipretide For Mitochondrial Diseases

9/27/2019 9:34:53 PM Biotech Stocks Facing FDA Decision In October 2019

8/23/2019 3:08:35 AM ALXN & Takeover Rumors, AMGN's JASMINE Blooms, CLSD Sees The Writing On The Wall

7/26/2019 8:47:39 AM Alexion Gets Positive Opinion From CHMP For SOLIRIS For Treatment Of NMOSD

7/26/2019 8:10:28 AM Alexion Gets Positive CHMP Opinion For SOLIRIS For Treatment Of NMOSD

7/24/2019 7:12:59 AM Alexion Boosts FY19 Outlook - Quick Facts

7/24/2019 6:52:48 AM Alexion Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates

7/24/2019 6:33:54 AM Alexion Q2 GAAP EPS $2.04; Non-GAAP EPS $2.64